|
|
Register Now for May Meeting
Spring NLARx Meeting in Charleston, West Virginia
Join us May 9th in West Virginia's state capital to catch up on the latest action on prescription drug issues in state legislatures and the courts, including generic drug savings & policies, datamining and Medicaid, and covering more people under Medicare Part D and much more.
|
NLARx Reports
Prescription Drugs: Policy Options for States More
Prescriber education program and discount card included in New York state budget More
|
|
In the StatesNEW YORK: Senate Passes Prescriber Education, Other Prescription Drug Measures in State Budget More
WEST VIRGINIA: Generic Drugs Help Curb Costs More
NEW JERSEY, WEST VIRGINIA: States Announce Programs to Help Uninsured Obtain Medications More
IOWA: Bill Limits Switches from Brand Name to Generic Epilepsy Medicine More
ALABAMA: Health Committee OKs Epilepsy Bill More
ALASKA: Eli Lilly Settles State' s Zyprexa Suit for $15 Million More
PENNSYLVANIA: House Passes Bill Limiting Insurance Rates Based on Health History More |
Outrage of the WeekDrug Makers Near Old Goal: A Legal Shield More |
Prices & Health Care Costs
33 States Have or Consider Prescription Drug
'Recycling' Programs To Help Uninsured More
Insured Have More Trouble Paying for Prescription Drugs as Copays Increase, Economy Worsens More
Drug Costs Rise as Economy Slides More
Pfizer, Glaxo Raise Prices as Drug Growth Declines More
|
Generics & Patent Policy
Unions Pounce on Patent Reform More
Generic Rivals Loom for AstraZeneca More
Patent reform contest heads to Senate floor More
FDA and University of Rhode Island College of Pharmacy to Hold Forum on Generic Drugs More
US court rejects new patent office rules More
Takeda, Abbott Win Prevacid Patent Ruling More
Teva Barred From Selling Generic of Aricept More
Seroquel may dodge generics, for now More
|
Pharma Watch
Biotech Industry Spent $6.6M on Lobbying More
Glaxo, An Angry Blogger And Free Speech More
Drug Research Increased $2.7 Billion in 2007 More
Pfizer Is Denied Access to JAMA Files More
Schering Job, Plant Cuts More
Drug Maker Cuts Risk
By Buying Others' Pills More
Merck CEO to head drug industry group More
|
PBM Watch
Interview with National PBM Expert Bob Garis More
Leveling the Playing Field in the PBM Industry More
Benefits managers' influence grows More
Will New Medco Electronic Safety Review System Compromise Privacy or Increase Marketing Opportunities? More
Schering Profits with Job, Plant Cuts More
Drug Maker Cuts Risk
By Buying Others' Pills More
Merck CEO to head drug industry group More
|
Fraud & Abuse
Big Sentence for Medicare Fraudster More
Seven Charged in $11 Million Medicare Fraud Linked to Fake HIV Clinic More
Otsuka Settle Abilify Off-Label Marketing Case for $4 Million More
Pfizer May Be Liable for Generic Neurontin Purchases in Class Action Suit More
Largest Medicare payment lawsuit settled More
Eli Lilly Settling Zyprexa Lawsuit More
False Claims Act Amendments, S. 2041, Voted Out of Senate Judiciary Committee More
|
Advertising & Marketing
Pharmaceutical Executive Magazine on Physician Gifting Crackdown More
House Committee Seeks Info on Marketing, 'Bundling' Contracts Related to Anemia Medications More
Prescription Drug TV Ads Include
Toll-Free Number, Web Site to Report Side Effects, Lawmakers Say More
Do Free Gifts Dictate Your Medical Care? More
National Physicians Alliance Urgs Docs to Go "Unbranded" More
|
Medicare
Medicare Payment Advisory Commission Looks at Disclosure, Conflicts More
Grassley Investigates Amgen's Aranesp Rebates and Discounts More
New CMS Rule on Part D Will Allow Some Low-Income Beneficiaries to Remain in Current Plans More
Kaiser Issues New Findings on Features and Trends for Medicare Drug Plans More
There's Money in 'Disease Management: Medicare Pilot Program Illustrates Difficulties of Reducing Costs More
CMS Issues Final E-Prescribing Standards Under Medicare Part D More
National Health Law Program on New CMS Regulations, the 2009 Budget, Bill of Interest More
|
Medicaid
Drug Manufacturers Oppose Increasing
Medicaid Rebate in Mental Health Proposal More
Lawsuit Alleges West Virginia Fails To Comply With Medicaid Rule Filing Law More
Overview and Impact of New Regulations More
Dingell Legislation Would Delay New Medicaid Regulations, Cutbacks, for One Year More
Pay/Go Rules Might Prevent Lawmakers from Blocking Proposed Medicaid Changes More
Budget-Balancing Health Care Cuts by States Might Disproportionately Hurt Low-Income
Populations More
|
Conflicts of Interest
Journal Reports Tobacco Money & GE Royalties in Lung Cancer Study
More
Health Journal Comes Clean More
|
More Goings on in CongressHouse Committee Seeks Info on Anemia Medication Marketing, 'Bundling' Contracts More
Grassley Investigates Amgen's Rebates More
Grassley Presses Merck, Schering on Vytorin Clinical Trial Results More |
Importation
Why You Can't Tell Where Your Medication Was Made More
Court Adviser Says Glaxo
Broke EU Antitrust Laws More
|
Safety & Clinical Trials
Third Circuit Rules in Favor of Preemption More
Grassley Requests Info on Delay of Results More
Study on Cholesterol Medication Vytorin More
UnitedHealth Says 'No Safety Issues' for Vytorin Pill More
FDA Safety Changes: Levaquin, Nexavar, AndroGel More
FDA Looking Into Singulair Suicide Risk More
Similar drug-name pairs nearly double 2004 tally More
Accusations of Delays in Releasing Drug Results More
One in 15 Children Harmed by Drug Overdose, Adverse Reaction While Hospitalized, Study Finds More
Avandia Freeze Proposed By Scottish Docs More
FDA Releases Five-Year Drug Safety Plan More
Pressured to Improve Safety, FDA Slashes Drug Approval Rate More
Medication 'worsens Alzheimer's' More
ANALYSIS - U.S. may compare medical products; companies wary More
The Drug Scare that Exposed a World of Hurt More
Three More European Countries Recall Heparin More
Blumenthal sues FDA over OxyContin inactivity More
|
Confidentiality
UCLA Hospital Employee Couldn't Contain Celeb Curiosity More
New York Gov. Paterson Announces $105M in Grants for Statewide Electronic Health Record System More
|
|
|
|
|
|
|
